Growth Metrics

Inspire Medical Systems (INSP) Long-Term Debt Repayments (2022)

Inspire Medical Systems recorded quarterly Long-Term Debt Repayments of $21.4 million in Q3 2022.

Inspire Medical Systems' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $21.4 million for Q3 2022.

  • In Q3 2022, Long-Term Debt Repayments changed N/A year-over-year to $21.4 million; the TTM figure through Dec 2023 stood at $21.4 million (changed 0.0% YoY), while the FY2022 annual figure was $24.5 million, changed N/A from the prior year.
  • Long-Term Debt Repayments came in at $21.4 million for Q3 2022 at Inspire Medical Systems.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $21.4 million in Q3 2022 to a low of $21.4 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Inspire Medical Systems 1.17 Bn 889.44 Mn 176.91 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 21.44 Mn
Sep 30, 2022 21.44 Mn